NCT03439527View on ClinicalTrials.gov

Multisystem Cell Therapy for Improvement of Urinary Continence

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 22, 2020

Primary Completion Date

September 3, 2021

Study Completion Date

October 21, 2021

Conditions
Urinary Stress Incontinence
Interventions
OTHER

Muscle Precursor Cells (MPCs), ATMP

The advanced therapeutic investigational product, the MPCs, is a living, autologous cell-product isolated from a biopsy of the patient's own musculus soleus.

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
collaborator

University Hospital Tuebingen

OTHER

collaborator

Salzburger Landeskliniken

OTHER

lead

University of Zurich

OTHER

NCT03439527 - Multisystem Cell Therapy for Improvement of Urinary Continence | Biotech Hunter | Biotech Hunter